CN107823213A - A kind of pork pig antibiotic medicine - Google Patents
A kind of pork pig antibiotic medicine Download PDFInfo
- Publication number
- CN107823213A CN107823213A CN201710836081.2A CN201710836081A CN107823213A CN 107823213 A CN107823213 A CN 107823213A CN 201710836081 A CN201710836081 A CN 201710836081A CN 107823213 A CN107823213 A CN 107823213A
- Authority
- CN
- China
- Prior art keywords
- parts
- antibiotic medicine
- pork pig
- cephazoline
- carbacephem
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7028—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages
- A61K31/7034—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages attached to a carbocyclic compound, e.g. phloridzin
- A61K31/7036—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages attached to a carbocyclic compound, e.g. phloridzin having at least one amino group directly attached to the carbocyclic ring, e.g. streptomycin, gentamycin, amikacin, validamycin, fortimicins
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/4353—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems
- A61K31/437—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems the heterocyclic ring system containing a five-membered ring having nitrogen as a ring hetero atom, e.g. indolizine, beta-carboline
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/47—Quinolines; Isoquinolines
- A61K31/4704—2-Quinolinones, e.g. carbostyril
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/54—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame
- A61K31/542—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame ortho- or peri-condensed with heterocyclic ring systems
- A61K31/545—Compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins, cefaclor, or cephalexine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/54—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame
- A61K31/542—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame ortho- or peri-condensed with heterocyclic ring systems
- A61K31/545—Compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins, cefaclor, or cephalexine
- A61K31/546—Compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins, cefaclor, or cephalexine containing further heterocyclic rings, e.g. cephalothin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/63—Compounds containing para-N-benzenesulfonyl-N-groups, e.g. sulfanilamide, p-nitrobenzenesulfonyl hydrazide
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
- A61K31/7048—Compounds having saccharide radicals and heterocyclic rings having oxygen as a ring hetero atom, e.g. leucoglucosan, hesperidin, erythromycin, nystatin, digitoxin or digoxin
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Molecular Biology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
The invention discloses a kind of pork pig antibiotic medicine, is manufactured by the raw material of following parts by weight：Ribostamycin, kanamycins, cephazoline, cefaloglycin, sulfa drugs, quinolone, carbacephem, cefadroxil, erythromycin, auxiliary material.Disease caused by can treating the microorganism infections such as most of bacteriums, Richettsia, mycoplasma, Chlamydia, conveyor screw using the antibiotic medicine, there is good immunosuppressive action.
Description
【Technical field】
The present invention relates to cultivation field, more particularly to a kind of pork pig antibiotic medicine.
【Background technology】
Tri-Biocin is called antibacterium medicine (antibacterial), also referred to as " antibacterial agent ", is not causing ambiguity
In the case of, antibacterium medicine can be also simply referred to as " antimicrobial ".Tri-Biocin and antibiotic (Antibiotics) are not identical
Concept, antibiotic are only a classification under Tri-Biocin.Tri-Biocin is except including antibiosis such as penicillin, tetracyclines
Element, in addition to the medicine such as antifungal (anti-fungalmedication) and sulfamido, quinolones.Tri-Biocin
(antibiotics) be by microorganism (including bacterium, fungi, actinomyces) or high animals and plants in life process produced by
The chemicals that there is antipathogen or other active a kind of secondary metabolites, other living cells development functions can be disturbed
Matter.A kind of therefore, it is proposed that pork pig antibiotic medicine.
【The content of the invention】
It is a primary object of the present invention to provide a kind of pork pig antibiotic medicine, can effectively solve asking in background technology
Topic.
To achieve the above object, the technical scheme taken of the present invention is：
A kind of pork pig antibiotic medicine, manufactured by the raw material of following parts by weight：
Ribostamycin 4-8 parts, kanamycins 10-20 parts, cephazoline 1-5 parts, cefaloglycin 4-8 parts, sulfa drugs
10-20 parts, quinolone 5-10 parts, carbacephem 10-20 parts, cefadroxil 8-12 parts, erythromycin 10-15 parts, auxiliary material 20-30
Part.
Preferably, the auxiliary material parts by weight are as follows：Vitamin A 5-10 parts, vitamin E 8-10 parts, fish meal 7-10 parts.
Preferably, parts by weight are as follows：4 parts of ribostamycin, 10 parts of kanamycins, 1 part of cephazoline, 4 parts of cefaloglycin, sulphur
10 parts of amine drug, 5 parts of quinolone, 10 parts of carbacephem, 8 parts of cefadroxil, 10 parts of erythromycin, 20 parts of auxiliary material.
Preferably, parts by weight are as follows：8 parts of ribostamycin, 20 parts of kanamycins, 5 parts of cephazoline, 8 parts of cefaloglycin, sulphur
20 parts of amine drug, 10 parts of quinolone, 20 parts of carbacephem, 12 parts of cefadroxil, 15 parts of erythromycin, 30 parts of auxiliary material.
Preferably, parts by weight are as follows：6 parts of ribostamycin, 15 parts of kanamycins, 3 parts of cephazoline, 6 parts of cefaloglycin, sulphur
15 parts of amine drug, 7 parts of quinolone, 15 parts of carbacephem, 10 parts of cefadroxil, 13 parts of erythromycin, 15 parts of auxiliary material.
Preferably, the preparation method of pork pig antibiotic medicine,
Step 1：Prepare a 1L and the good container of seal, then by ribostamycin, kanamycins, cephazoline,
Cefaloglycin, sulfa drugs, quinolone, carbacephem, cefadroxil, erythromycin are sequentially placed into container, are often put into
A kind of raw material i.e. do it is of short duration shake up, be sequentially placed into a kind of lower raw material again afterwards, obtain product A.
Step 2：Auxiliary material is uniformly put into container, and mixed with product A, obtains finished product B.
Compared with prior art, the present invention has the advantages that：It can be treated using the antibiotic medicine most of
Disease caused by the microorganism infections such as bacterium, Richettsia, mycoplasma, Chlamydia, conveyor screw, there is good immunosupress to make
With.
【Embodiment】
To be easy to understand the technical means, the inventive features, the objects and the advantages of the present invention, with reference to
Embodiment, the present invention is expanded on further.
A kind of pork pig antibiotic medicine, manufactured by the raw material of following parts by weight：
Ribostamycin 4-8 parts, kanamycins 10-20 parts, cephazoline 1-5 parts, cefaloglycin 4-8 parts, sulfa drugs
10-20 parts, quinolone 5-10 parts, carbacephem 10-20 parts, cefadroxil 8-12 parts, erythromycin 10-15 parts, auxiliary material 20-30
Part.
The preparation method of pork pig antibiotic medicine,
Step 1：Prepare a 1L and the good container of seal, then by ribostamycin, kanamycins, cephazoline,
Cefaloglycin, sulfa drugs, quinolone, carbacephem, cefadroxil, erythromycin are sequentially placed into container, are often put into
A kind of raw material i.e. do it is of short duration shake up, be sequentially placed into a kind of lower raw material again afterwards, obtain product A.
Step 2：Auxiliary material is uniformly put into container, and mixed with product A, obtains finished product B.
Embodiment 1：
Further, parts by weight are as follows：4 parts of ribostamycin, 10 parts of kanamycins, 1 part of cephazoline, 4 parts of cefaloglycin,
10 parts of sulfa drugs, 5 parts of quinolone, 10 parts of carbacephem, 8 parts of cefadroxil, 10 parts of erythromycin, 20 parts of auxiliary material.
Embodiment 2：
Further, parts by weight are as follows：8 parts of ribostamycin, 20 parts of kanamycins, 5 parts of cephazoline, 8 parts of cefaloglycin,
20 parts of sulfa drugs, 10 parts of quinolone, 20 parts of carbacephem, 12 parts of cefadroxil, 15 parts of erythromycin, 30 parts of auxiliary material.
Embodiment 3：
Further, parts by weight are as follows：6 parts of ribostamycin, 15 parts of kanamycins, 3 parts of cephazoline, 6 parts of cefaloglycin,
15 parts of sulfa drugs, 7 parts of quinolone, 15 parts of carbacephem, 10 parts of cefadroxil, 13 parts of erythromycin, 15 parts of auxiliary material.
It is micro- that most of bacteriums, Richettsia, mycoplasma, Chlamydia, conveyor screw etc. can be treated using the antibiotic medicine
Disease caused by biological infection, there is good immunosuppressive action.
The general principle and principal character and advantages of the present invention of the present invention has been shown and described above.The technology of the industry
Personnel are it should be appreciated that the present invention is not limited to the above embodiments, and the simply explanation described in above-described embodiment and specification is originally
The principle of invention, without departing from the spirit and scope of the present invention, various changes and modifications of the present invention are possible, these changes
Change and improvement all fall within the protetion scope of the claimed invention.The claimed scope of the invention by appended claims and its
Equivalent thereof.
Claims (6)
1. a kind of pork pig antibiotic medicine, it is characterised in that manufactured by the raw material of following parts by weight：
Ribostamycin 4-8 parts, kanamycins 10-20 parts, cephazoline 1-5 parts, cefaloglycin 4-8 parts, sulfa drugs 10-20
Part, quinolone 5-10 parts, carbacephem 10-20 parts, cefadroxil 8-12 parts, erythromycin 10-15 parts, auxiliary material 20-30 parts.
2. pork pig antibiotic medicine according to claim 1, it is characterised in that the auxiliary material parts by weight are as follows：Vitamin
A5-10 parts, vitamin E 8-10 parts, fish meal 7-10 parts.
3. pork pig antibiotic medicine according to claim 1, it is characterised in that parts by weight are as follows：4 parts of ribostamycin, card
10 parts of that mycin, 1 part of cephazoline, 4 parts of cefaloglycin, 10 parts of sulfa drugs, 5 parts of quinolone, 10 parts of carbacephem, cephalo
8 parts of amoxycillin, 10 parts of erythromycin, 20 parts of auxiliary material.
4. pork pig antibiotic medicine according to claim 1, it is characterised in that parts by weight are as follows：8 parts of ribostamycin, card
20 parts of that mycin, 5 parts of cephazoline, 8 parts of cefaloglycin, 20 parts of sulfa drugs, 10 parts of quinolone, 20 parts of carbacephem, head
12 parts of spore amoxycillin, 15 parts of erythromycin, 30 parts of auxiliary material.
5. pork pig antibiotic medicine according to claim 1, it is characterised in that parts by weight are as follows：6 parts of ribostamycin, card
15 parts of that mycin, 3 parts of cephazoline, 6 parts of cefaloglycin, 15 parts of sulfa drugs, 7 parts of quinolone, 15 parts of carbacephem, cephalo
10 parts of amoxycillin, 13 parts of erythromycin, 15 parts of auxiliary material.
6. the preparation method of pork pig antibiotic medicine, it is characterised in that
Step 1：Prepare a 1L and the good container of seal, then by ribostamycin, kanamycins, cephazoline, cephalo
Come star, sulfa drugs, quinolone, carbacephem, cefadroxil, erythromycin to be sequentially placed into container, be often put into one kind
Raw material i.e. do it is of short duration shake up, be sequentially placed into a kind of lower raw material again afterwards, obtain product A.
Step 2：Auxiliary material is uniformly put into container, and mixed with product A, obtains finished product B.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201710836081.2A CN107823213A (en) | 2017-09-16 | 2017-09-16 | A kind of pork pig antibiotic medicine |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201710836081.2A CN107823213A (en) | 2017-09-16 | 2017-09-16 | A kind of pork pig antibiotic medicine |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN107823213A true CN107823213A (en) | 2018-03-23 |
Family
ID=61643329
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN201710836081.2A Pending CN107823213A (en) | 2017-09-16 | 2017-09-16 | A kind of pork pig antibiotic medicine |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN107823213A (en) |
Citations (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN104208076A (en) * | 2013-05-29 | 2014-12-17 | 天津金耀集团有限公司 | Compound inhalation preparation containing cephalosporin antibiotic and glucocorticoid |
| CN104884092A (en) * | 2013-01-14 | 2015-09-02 | 沃克哈特有限公司 | Compositions and methods for treating bacterial infections |
-
2017
- 2017-09-16 CN CN201710836081.2A patent/CN107823213A/en active Pending
Patent Citations (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN104884092A (en) * | 2013-01-14 | 2015-09-02 | 沃克哈特有限公司 | Compositions and methods for treating bacterial infections |
| CN104208076A (en) * | 2013-05-29 | 2014-12-17 | 天津金耀集团有限公司 | Compound inhalation preparation containing cephalosporin antibiotic and glucocorticoid |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN110123806B (en) | Application of epigallocatechin gallate in preparation of anti-streptococcus suis drugs | |
| Tyor et al. | Biochemical characterization and antibacterial properties of fish skin mucus of fresh water fish, Hypophthalmichthys nobilis | |
| Lam et al. | The effect of discontinuation of postmilking teat disinfection in low somatic cell count herds. II. Dynamics of intramammary infections | |
| Clothier et al. | Antimicrobial susceptibility patterns and sensitivity to tulathromycin in goat respiratory bacterial isolates | |
| CN107823213A (en) | A kind of pork pig antibiotic medicine | |
| Santos et al. | Trichoderma asperelloides ethanolic extracts efficiently inhibit Staphylococcus growth and biofilm formation | |
| EP0579488A1 (en) | Composition for treating mastitis and metritis | |
| KR101816603B1 (en) | Antibacterial Composition for Antibiotics Resistant Staphylococcus aureus inhibition Comprising morin | |
| Lalchhandama | History of penicillin | |
| CN106220647A (en) | A kind of cefathiamidine compound and preparation thereof and preparation method | |
| Aarestrup et al. | Use of antimicrobials in food animal production | |
| CN109925503B (en) | Traditional Chinese medicine injection for reversing drug resistance of staphylococcus aureus | |
| CN101978947B (en) | Long-acting Cefquinome sulfate injection and preparation method thereof | |
| CN107320727A (en) | Antibacterial peptide and antibiotic combinations antibacterials and its application method | |
| Petkova et al. | In vitro effect of tetracycline antibiotics on Trueperella pyogenes isolated from cows with metritis. | |
| ES442505A1 (en) | Antibiotic aminoglycosides, processes of preparation and pharmaceutical compositions | |
| Torres et al. | Antimicrobial resistance in wild boar in europe: Present knowledge and future challenges | |
| del Río-Rodríguez et al. | Aerobic microflora of imported ornamental fish from Singapore and South America | |
| Shahrani et al. | Study of frequency and antimicrobial resistance of Lactococcus garvieae in rainbow trout fish in Chaharmahal va Bakhtiari Province | |
| RU2391940C2 (en) | Method for sanitisation of rooster sperm | |
| CN103271924B (en) | Injection-use pharmaceutical composition comprising cefathiamidine and tazobactam sodium | |
| KR101740993B1 (en) | Antibacterial Composition for Antibiotics Resistant Staphylococcus aureus inhibition Comprising luteolin | |
| GB1279408A (en) | 5-nitro-2-furfurylideneamino-oxazolidinones | |
| KN et al. | Antimicrobial Potential of Helicanthus elastica (Desr.) Danser-A less explored Indian mistletoe Growing on Mango Trees. | |
| Brito et al. | Antimicrobial resistance of bacterial agents of bovine mastitis from dairy properties in the metropolitan region of São Luís–MA |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PB01 | Publication | ||
| PB01 | Publication | ||
| SE01 | Entry into force of request for substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| WD01 | Invention patent application deemed withdrawn after publication |
Application publication date: 20180323 |
|
| WD01 | Invention patent application deemed withdrawn after publication |